Clinical Research Directory
Browse clinical research sites, groups, and studies.
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Sponsor: University of Colorado, Denver
Summary
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Official title: A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2015-01
Completion Date
2027-01
Last Updated
2025-02-28
Healthy Volunteers
Yes
Conditions
Interventions
Endoscopic eradication therapies (EET)
Endoscopic eradication therapies (EET) includes endoscopic mucosal resection (EMR), which describes the process by which the area most likely to harbor highest grade of dysplasia/neoplasia is removed; radiofrequency ablation (RFA), which describes the process by which Barrett's segments are removed via burning/ablation; and cryotherapy.
Esophagectomy
The esophagus is surgically removed
Chemotherapy
Chemical substances are used to treat cancer
Radiation
Cancer cells are destroyed by radiation therapy.
Locations (4)
UCLA Medical Center
Los Angeles, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Washington University
St Louis, Missouri, United States